Effect of prophylactic use of hydrolyzed protein formula on gastrointestinal diseases and physical growth in preterm infants: a Meta analysis
XIANG Ling-Ling, HU Yuan-Yuan, XIA Xu-Hua, HUA Zi-Yu
Department of Neonatology, Children's Hospital of Chongqing Medical University/Ministry of Education Key Laboratory of Child Development and Disorders/National Clinical Research Center for Child Health and Disorders/China International Science and Technology Cooperation Base of Child Development and Critical Disorders/Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
Abstract:Objective To systematically evaluate the effect of prophylactic use of hydrolyzed protein formula on gastrointestinal diseases and physical development in preterm infants. Methods A computerized search was performed in the databases including China National Knowledge Infrastructure, Wanfang Data, Weipu, PubMed, Embase, and the Cochrane Library to identify randomized controlled trials of the effect of prophylactic use of hydrolyzed protein formula on gastrointestinal diseases and physical growth in preterm infants. RevMan 5.3 software was used to perform a Meta analysis for the included studies. Results A total of 7 randomized controlled studies were included. The results of Meta analysis showed that compared with the whole protein formula, the prophylactic use of hydrolyzed protein formula could reduce the risk of neonatal necrotizing enterocolitis (RR=0.40, P=0.04) and feeding intolerance (RR=0.40, P=0.005), and had no significant effect on the growth of weight, length and head circumference (P>0.05). Conclusions Compared with the whole protein formula, the prophylactic use of hydrolyzed protein formula in preterm infants may reduce the occurrence of necrotizing enterocolitis and feeding intolerance, and can meet the nutrient requirement of physical development. However, the evidence is limited, and the results of this study cannot support the routine prophylactic use of hydrolyzed protein formula in preterm infants.
XIANG Ling-Ling,HU Yuan-Yuan,XIA Xu-Hua et al. Effect of prophylactic use of hydrolyzed protein formula on gastrointestinal diseases and physical growth in preterm infants: a Meta analysis[J]. CJCP, 2022, 24(2): 169-175.
Staelens S, Van den Driessche M, Barclay D, et al. Gastric emptying in healthy newborns fed an intact protein formula, a partially and an extensively hydrolysed formula[J]. Clin Nutr, 2008, 27(2): 264-268. PMID: 18280619. DOI: 10.1016/j.clnu.2007.12.009.
Corvaglia L, Mariani E, Aceti A, et al. Extensively hydrolyzed protein formula reduces acid gastro-esophageal reflux in symptomatic preterm infants[J]. Early Hum Dev, 2013, 89(7): 453-455. PMID: 23642476. DOI: 10.1016/j.earlhumdev.2013.04.003.
von Berg A, Filipiak-Pittroff B, Schulz H, et al. Allergic manifestation 15 years after early intervention with hydrolyzed formulas: the GINI study[J]. Allergy, 2016, 71(2): 210-219. PMID: 26465137. PMCID: PMC4738469. DOI: 10.1111/all.12790.
Kuzma-O'Reilly B, Duenas ML, Greecher C, et al. Evaluation, development, and implementation of potentially better practices in neonatal intensive care nutrition[J]. Pediatrics, 2003, 111(4 Pt 2): e461-e470. PMID: 12671166.
Oremus M, Wolfson C, Perrault A, et al. Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials[J]. Dement Geriatr Cogn Disord, 2001, 12(3): 232-236. PMID: 11244218. DOI: 10.1159/000051263.
Picaud JC, Rigo J, Normand S, et al. Nutritional efficacy of preterm formula with a partially hydrolyzed protein source: a randomized pilot study[J]. J Pediatr Gastroenterol Nutr, 2001, 32(5): 555-561. PMID: 11429516. DOI: 10.1097/00005176-200105000-00012.
Mihatsch WA, Franz AR, H?gel J, et al. Hydrolyzed protein accelerates feeding advancement in very low birth weight infants[J]. Pediatrics, 2002, 110(6): 1199-1203. PMID: 12456919. DOI: 10.1542/peds.110.6.1199.
Maggio L, Zuppa AA, Sawatzki G, et al. Higher urinary excretion of essential amino acids in preterm infants fed protein hydrolysates[J]. Acta Paediatr, 2005, 94(1): 75-84. PMID: 15858965. DOI: 10.1111/j.1651-2227.2005.tb01792.x.
Florendo KN, Bellflower B, van Zwol A, et al. Growth in preterm infants fed either a partially hydrolyzed whey or an intact casein/whey preterm infant formula[J]. J Perinatol, 2009, 29(2): 106-111. PMID: 18716627. DOI: 10.1038/jp.2008.124.
Baldassarre ME, Di Mauro A, Fanelli M, et al. Shorter time to full preterm feeding using intact protein formula: a randomized controlled trial[J]. Int J Environ Res Public Health, 2019, 16(16): 2911. PMID: 31416171. PMCID: PMC6720977. DOI: 10.3390/ijerph16162911.
30 World Health Organization. A randomized, controlled, double-blind parallel group trial to study the effects of an infant formula containing partially hydrolysed proteins on growth and tolerance in healthy term infants [EB/OL]. (2021-07-31)[2021-09-11]. https://trialsearch.who.int/?TrialID=NL9536.
31 U.S. National Library of Medicine. Infants fed extensively hydrolyzed casein-based infant formulas[EB/OL]. (2019-08-05)[2021-08-14]. https://clinicaltrials.gov/ct2/show/NCT04006236.
32 World Health Organization. Growth and tolerance of healthy term infants fed infant formula with 100% whey protein hydrolysate or intact milk proteins (penguin project)[EB/OL]. (2018-11-27)[2021-08-14]. https://trialsearch.who.int/?TrialID=DRKS00016462.